Literature DB >> 23258480

Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma.

Na Cheng1, Yandong Li, Ze-Guang Han.   

Abstract

UNLABELLED: Hepatocellular carcinoma (HCC) is one of the most common cancers and shows a propensity to metastasize and infiltrate adjacent and more distant tissues. However, the mechanisms that contribute to tumor metastasis remain unclear. Here we evaluate the effect of Argonaute2 (Ago2), a member of the Ago gene family that plays a role in short interfering RNA-mediated gene silencing, on HCC tumorigenesis, and metastasis. We found that Ago2 was frequently up-regulated in HCC specimens compared to that in corresponding adjacent nontumor liver. Interestingly, Ago2 overexpression can promote proliferation, colony formation in an anchor-independent manner, migration, tumorigenicity, and metastasis of HCC cells in vivo; in contrast, Ago2 knockdown can restrict anchor-independent colony formation, migration, and tumor metastasis of HCC cells in vivo. However, known microRNAs related to tumor metastasis appeared not be deregulated with Ago2 overexpression in HCC cells; even the knockdown of Dicer, which is responsible for microRNA biosynthesis, did not abolish the actions of Ago2 in HCC cells. Significantly, focal adhesion kinase (FAK), a well-known molecule associated with tumor metastasis, was up-regulated as a result of Ago2 overexpression. Chromatin immunoprecipitation assay showed that Ago2 can bind to the FAK promoter and then trigger its transcription. Moreover, an increased DNA copy number of Ago2 on chromosome 8q24, one of the most frequent DNA amplified regions, was validated and shown by way of fluorescence in situ hybridization.
CONCLUSION: Our data demonstrate that Ago2 overexpression, as a result of genomic DNA amplification, promotes HCC tumorigenesis and metastasis by way of up-regulation of FAK transcription, thereby providing new insight into HCC progression and Ago2 function.
Copyright © 2012 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23258480     DOI: 10.1002/hep.26202

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

Review 1.  Demystifying the nuclear function of Argonaute proteins.

Authors:  Vera Huang; Long-Cheng Li
Journal:  RNA Biol       Date:  2014-01-02       Impact factor: 4.652

2.  Argonaute 2 promotes angiogenesis via the PTEN/VEGF signaling pathway in human hepatocellular carcinoma.

Authors:  Zhen-long Ye; Yao Huang; Lin-fang Li; Hai-li Zhu; Hai-xia Gao; Hui Liu; Sai-qun Lv; Zeng-hui Xu; Luo-ning Zheng; Tao Liu; Jing-lei Zhang; Hua-jun Jin; Qi-jun Qian
Journal:  Acta Pharmacol Sin       Date:  2015-05-04       Impact factor: 6.150

3.  Investigation of key microRNAs associated with hepatocellular carcinoma using small RNA-seq data.

Authors:  Lian-Jie Lin; Yan Lin; Yu Jin; Chang-Qing Zheng
Journal:  Mol Biol Rep       Date:  2014-03-13       Impact factor: 2.316

4.  The RNA-editing enzyme ADAR promotes lung adenocarcinoma migration and invasion by stabilizing FAK.

Authors:  Elianna M Amin; Yuan Liu; Su Deng; Kay See Tan; Neel Chudgar; Marty W Mayo; Francisco Sanchez-Vega; Prasad S Adusumilli; Nikolaus Schultz; David R Jones
Journal:  Sci Signal       Date:  2017-09-19       Impact factor: 8.192

5.  Cellular Approaches in Investigating Argonaute2-Dependent RNA Silencing.

Authors:  Cai Zhang; Joonbae Seo; Takahisa Nakamura
Journal:  Methods Mol Biol       Date:  2018

Review 6.  FAK in cancer: mechanistic findings and clinical applications.

Authors:  Florian J Sulzmaier; Christine Jean; David D Schlaepfer
Journal:  Nat Rev Cancer       Date:  2014-08-07       Impact factor: 60.716

Review 7.  Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials.

Authors:  Bruna Scaggiante; Maryam Kazemi; Gabriele Pozzato; Barbara Dapas; Rosella Farra; Mario Grassi; Fabrizio Zanconati; Gabriele Grassi
Journal:  World J Gastroenterol       Date:  2014-02-07       Impact factor: 5.742

8.  Up-regulation of Ago2 expression in gastric carcinoma.

Authors:  Jin Zhang; Xiang-shan Fan; Cai-xia Wang; Biao Liu; Qin Li; Xiao-jun Zhou
Journal:  Med Oncol       Date:  2013-06-18       Impact factor: 3.064

9.  Argonaute 2 is up-regulated in tissues of urothelial carcinoma of bladder.

Authors:  Feng-Qiang Yang; Jian-Hua Huang; Min Liu; Feng-Ping Yang; Wei Li; Guang-Chun Wang; Jian-Ping Che; Jun-Hua Zheng
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

Review 10.  New PARP targets for cancer therapy.

Authors:  Sejal Vyas; Paul Chang
Journal:  Nat Rev Cancer       Date:  2014-06-05       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.